Navigation Links
Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Date:8/19/2007

for the treatment of Fabry disease and Plicera(TM) for the treatment of Gaucher disease. The Company is also conducting Phase I clinical trials of AT2220 for the treatment of Pompe disease.

Forward-Looking Statements

Amicus cautions you that statements included in this press release that are not a description of historical facts are "forward-looking statements" within the meaning of Section 21E of the Private Securities Litigation Reform Act of 1995. Words such as, but not limited to, "look forward to," "believe," "expect," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "should," and "could," and similar expressions or words identify forward-looking statements. Such forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties. The inclusion of forward-looking statements should not be regarded as a representation by Amicus that any of its plans will be achieved. Any or all of the forward-looking statements in this press release may turn out to be wrong. They can be affected by inaccurate assumptions Amicus might make or by known or unknown risks and uncertainties. For example, with respect to statements regarding the potential progress and results of clinical trials, actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the business of Amicus, including, without limitation: the respective Phase II clinical trials for Amigal(TM) and Plicera(TM), and the Phase I clinical trial for AT2220 may not proceed in the timeframes or in the manner Amicus expects or at all. Further, the results of earlier clinical trials may not be predictive of future results; Amicus and its licensors may not be able to obtain, maintain and successfully enforce adequate patent and other intellectual property protection of its product candidates; and other risks detailed in the public filings of Amicus with
'/>"/>

SOURCE Amicus Therapeutics

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amicus Therapeutics Presents Positive Results From Phase 1 Clinical Studies of Plicera for Gaucher Disease
2. Amicus Therapeutics Presents Preclinical Data from Studies of Plicera for Gaucher Disease
3. Amicus Therapeutics Presents Data From Preclinical and Phase 1 Studies of Amigal for Fabry Disease
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
7. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
8. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
9. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
10. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
11. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... SAN CLEMENTE, Calif. , Nov. 21, 2014 /PRNewswire/ ... Lab Coats and Performance Scrubs carried out a new ... the medical industry,s very first "limited edition" lab ... the first female professors of surgery in the world. ... departure from its unisex predecessors, with a sleek envelope ...
(Date:11/21/2014)... -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) is proud ... Vision, Innovation, and Leadership has been awarded to Stuart ... an individual who has had a significant impact on the ... several decades. "I am honored to receive the ... Ph.D., CEO of PTC Therapeutics, Inc. "When I founded PTC ...
(Date:11/21/2014)... research firm Kalorama information says that 2014 will be ... medical device industry.  The firm thinks the $360 billion-dollar ... growth this year, which led firms to look to ... entrance by acquisition into new competitive zones.  The company ... Global Market for Medical Devices, 5 th Edition ...
Breaking Medicine Technology:Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2
... Stereotaxis, Inc. (NASDAQ: STXS ) today reported financial ... Third Quarter 2011 Financial Results Revenue ... the year ago period.  The decrease was primarily due to ... for a more efficient solution for complex ablation procedures and ...
... Nov. 7, 2011 Alexza Pharmaceuticals, Inc. (Nasdaq: ... fiscal quarter ended September 30, 2011 and provided a ... September 30, 2011 and 2010, as reported in accordance ... (GAAP), were $13.4 million and $0.6 million, respectively.  The ...
Cached Medicine Technology:Stereotaxis Reports Third Quarter Financial Results 2Stereotaxis Reports Third Quarter Financial Results 3Stereotaxis Reports Third Quarter Financial Results 4Stereotaxis Reports Third Quarter Financial Results 5Stereotaxis Reports Third Quarter Financial Results 6Stereotaxis Reports Third Quarter Financial Results 7Stereotaxis Reports Third Quarter Financial Results 8Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 2Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 3Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 4Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 5Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 6Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 7
(Date:11/21/2014)... Los Angeles, CA (PRWEB) November 21, 2014 ... is now creating picture-perfect smiles for patients in preparation ... are bonded to the fronts of teeth, look completely ... flaws. In certain situations, veneers are also valued for ... for most patients and can be used on one ...
(Date:11/21/2014)... 21, 2014 (HealthDay News) -- Scientists say they,ve mapped the ... from a British man,s brain, in hopes it might help ... 21 in the journal Genome Biology , the tapeworm ... of Chinese ethnicity. "This infection is so rare worldwide ... not diagnosed ... until the worm was pulled out from ...
(Date:11/21/2014)... 21, 2014 The Ohio Children’s Trust ... Ohio Chapter, American Academy of Pediatrics (Ohio AAP, ... education to parents and caregivers throughout Ohio. The new ... 30, 2015, provides $75,000 to continue the campaign that ... Trust Fund is excited to continue partnering with the ...
(Date:11/21/2014)... Midway through the research period for the ... Directory of Health Plans, preliminary data shows volatility in ... Plans is a comprehensive resource with enrollment data and ... The 2015 edition will be available in ... Databases Division, the company’s exclusive in-house research team, have ...
(Date:11/21/2014)... November 21, 2014 CDT PLUS! ... dental practice. It includes everything needed to process dental ... Coding with CDT , CDT 2015 codes are mandatory ... 1, 2014 - December 31, 2014. Dental professionals must ... services on dental claims. There are significant changes in ...
Breaking Medicine News(10 mins):Health News:Los Angeles Porcelain Veneers Dentist, Dr. Kevin Sands, Now Creates Picture-Perfect Smiles for Patients for the Holiday Season 2Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:Ohio AAP and Ohio Children’s Trust Fund Continue Partnership for Safe Sleep Education Campaign 2Health News:Ohio AAP and Ohio Children’s Trust Fund Continue Partnership for Safe Sleep Education Campaign 3Health News:Data from Atlantic Information Services’s Forthcoming Directory Shows Volatility in U.S. Health Care Market 2Health News:PMIC Announces CDT PLUS! 2015, the Ultimate Coding Reference for Dentists and Oral Surgeons 2
... Dr Mukesh Haikerwal, today welcomed the Northern Territory ... babies, and encouraged other jurisdictions to follow suit ... disease. ,The NT’s decision came after the ... that it would not be cost-effective to provide ...
... in the science of vaccination has yielded a much-improved ... eradicating and help in fighting// many infectious diseases. ... been slow and painstaking have been so beneficial in ... It was unfortunate however that the health experts in ...
... drink companies have reached an agreement with courts in ... benzene. In Zone Brands Inc, and TalkingRain Beverage// Co ... in their drinks, which increased benzene formation. ... in soft drinks or fruit juices can cause formation ...
... effort to motivate beekeepers to produce sugar-free herbal honey, the ... Pradesh.// ,The National Horticulture Board (NHB) has sent ... to be distributed in 10 of 12 districts in the ... be fed on the stevia herbal plant leaves that are ...
... Jacques Ramsay has recommended that Canadians suffering from severe ... the Twinject, which// provides a double dose in the ... He has also called for manufacturers to ... patients. ,The recommendations follow the investigation into ...
... Employers' Federation (JEF) has confirmed that 22 organizations have ... stigma and discrimination// associated with AIDS in the working ... and labor companies, the employers group has been conducting ... to combat HIV/AIDS discrimination. Creation of the national ...
Cached Medicine News:Health News:Remarkable Progress In Development Of Vaccines 2Health News:Remarkable Progress In Development Of Vaccines 3Health News:Remarkable Progress In Development Of Vaccines 4
... network of door controllers, RoamAlert Integrity Plus ... the coverage area. These receivers pick up ... similar in size and shape, this tag ... RoamAlert ECO and RoamAlert Integrity in one ...
... Radio Frequency Identification (RFID) helps incorporate people ... into the healthcare value chain. The power ... us further automate and optimize business activities ... to tracking pharmaceutical inventories, RFID offers tremendous ...
VACUETTE PaediatricMulti-Sample Needle...
37°C incubator for DianaGel cards....
Medicine Products: